Functional Activation and Targeting of Exosomes for Regenerative Medicine
Functional Activation and Targeting of Exosomes for Regenerative Medicine
批准号:
10418678
负责人:
PRAVEEN GAJENDRAREDDY
金额:
$37.6万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-15 至 2024-05-31
关键词:
3-DimensionalAffinityAntibodiesArchitectureAutologousBMP2 geneBindingBiocompatible MaterialsBiological ModelsBiomimeticsBone RegenerationCalvariaCancer BiologyCartilageCell Fate ControlCell LineageCell physiologyCellsCharacteristicsClinicalCollagen Type IDefectDiseaseDosage FormsEffector CellEndocytosisEngineeringEvaluationExtracellular MatrixFDA approvedFibronectinsGenerationsGoalsGoldGrowth FactorHardnessHeartHistologyHourITGA5 geneImmune responseImmunologicsImmunologyIn VitroInjuryIntegrinsInvestigationKineticsKnowledgeLabelLaboratoriesLipidsLiverMediatingMesenchymal DifferentiationMesenchymal Stem CellsMicroRNAsModelingMuscleNaturePancreasParentsPlayProcessProductionProteinsRGD (sequence)RattusRegenerative MedicineRoleSignal TransductionSiteSkinSpecificitySystemTherapeuticTissue EngineeringTissuesTranslationsUndifferentiatedbasebonebone repaircell typedosageengineered exosomesexosomeexperienceexperimental studygenetic informationimmunoreactionin vivoin vivo evaluationmorphogensnanonanoindentationnanoscalenanovesicleosteoblast differentiationosteogenicprotein expressionscaffoldselective expressionstem cell differentiationstem cell exosomesstem cell functionstem cellstissue regenerationtool
中文摘要
摘要:
干细胞谱系确定(SCLD)是成功的必要和重要的步骤
由于疾病或损伤而失去的组织的再生。现有的组织工程方法使用了
生长因子和形态因子以及相关的生物材料,以实现SCLD。然而,这种方法是为了
SCLD受到几个因素的限制,如剂量、递送、异位活性、不良免疫学
并发症和分化异常。由于这些限制,单一形态系统具有
要么导致严重的临床并发症(来自FDA批准的生长因子,如BMP2),要么失败了
在翻译上取得成功。这一小时的需要是对这种单一形态因子/生长因子的替代
该系统本质上是仿生的,不会对翻译构成同样的威胁。在这方面,使用
由于它们的仿生性质,即它们能够被接受者内吞,所以外切体的特性是有益的
细胞及其免疫阳性反应。然而,有两个基本问题需要调查
帮助使用外切体作为纳米仿生工具,以实现再生医学中的SCLD。它们是:1.
外切体能靶向生物材料进行局部递送吗?2.外切体组分能否被修饰以
诱导组织特异性SCLD?这一应用程序是为弥合这一知识鸿沟所做的努力。我们建议
将靶向性和谱系特异性功能引入外体,以产生功能激活的
靶向外切体(命运)。在本应用中,我们将使用骨再生作为模型系统来研究
再生医学命运的产生、评价与应用。我们提出了三个具体目标来
实现这一目标。在目标1中,我们将设计具有增强与ECM蛋白结合特性的外切体
I型胶原和纤维连接蛋白,以实现生物材料介导的部位特异性靶向。在目标2中,我们将
使用两种不同的方法将骨诱导功能设计到靶向外体中并评估
由此产生的命运在体外。在目标3中,我们将评估在目标中生成的命运的目标和功能
2在体临界大小的大鼠颅骨缺损模型。这些研究的成功完成将有助于
证明细胞衍生的纳米囊泡(外体)可以被设计成具有特性
增强SCLD以进行组织特异性再生所需的。
英文摘要
Summary:
Stem Cell Lineage Determination (SCLD) is a necessary and important step required for successful
regeneration of tissues lost due to disease or injury. Existing tissue engineering approaches employ the use of
growth factors and morphogens along with relevant biomaterials to achieve SCLD. However, this approach to
SCLD is limited by several factors such as dosage, delivery, ectopic activity, adverse immunological
complications and aberrant differentiation. As a result of these limitations, the single morphogen system has
either caused significant clinical complications (from FDA approved growth factors such as BMP2) or has failed
to be translationally successful. The need of the hour is a replacement for this single morphogen/growth factor
system that is biomimetic in nature and does not pose the same threats to translation. In this regard, the use
of exosomes can be beneficial owing to their biomimetic nature, their ability to be endocytosed by recipient
cells and their positive immunological reactions. However, two fundamental questions need investigation to
aid the use of exosomes as nano biomimetic tools to achieve SCLD in regenerative medicine. They are: 1.
Can exosomes be targeted to biomaterials for localized delivery? 2. Can exosomal composition be modified to
induce tissue-specific SCLD? This application is an effort to bridge this knowledge gap. We propose to
engineer targetability and lineage-specific functionality into exosomes to generate Functionally Activated
Targeted Exosomes (FATE). In this application, we will use bone regeneration as a model system to study the
generation, evaluation and application of FATE for regenerative medicine. We propose three specific aims to
achieve this goal. In Aim 1, we will engineer exosomes with enhanced binding characteristics to ECM proteins
type I collagen and Fibronectin to enable biomaterial-mediated site-specific targeting. In Aim 2, we will
engineer osteoinductive functionality into the targeting exosomes using two distinct approaches and evaluate
the resulting FATE in vitro. In Aim 3, we will evaluate the targeting and functionality of FATE generated in aim
2 in vivo in a critical size rat calvarial defect model. The successful completion of these studies will serve as
proof-of-principle that cell-derived nano vesicles (exosomes) can be engineered to possess characteristics
required to enhance SCLD for tissue-specific regeneration.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3390/cells11182851
发表时间:
2022-09-13
期刊:
Cells
影响因子:
6
作者:
[]
通讯作者:
DOI:
10.1016/j.actbio.2021.03.030
发表时间:
2021-05
期刊:
Acta biomaterialia
影响因子:
9.7
作者:
[Huang CC, Kang M, Shirazi S, Lu Y, Cooper LF, Gajendrareddy P, Ravindran S]
通讯作者:
Ravindran S
DOI:
10.3389/fcell.2023.1127594
发表时间:
2023
期刊:
Frontiers in cell and developmental biology
影响因子:
5.5
作者:
[]
通讯作者:
DOI:
10.1016/j.biomaterials.2022.121903
发表时间:
2022-12
期刊:
Biomaterials
影响因子:
14
作者:
[]
通讯作者:
DOI:
10.3389/fimmu.2022.878194
发表时间:
2022
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[]
通讯作者:
Functional Activation and Targeting of Exosomes for Regenerative Medicine
-
批准号:10165690
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2018
-
负责人:PRAVEEN GAJENDRAREDDY
-
依托单位:
The Role of Stress Induced Hypoxia in Periodontitis
-
批准号:7840721
-
项目类别:
-
资助金额:$1.35万
-
财政年份:2009
-
负责人:PRAVEEN GAJENDRAREDDY
-
依托单位:
The Role of Stress Induced Hypoxia in Periodontitis
-
批准号:7643322
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2008
-
负责人:PRAVEEN GAJENDRAREDDY
-
依托单位:
The Role of Stress Induced Hypoxia in Periodontitis
-
批准号:7468916
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2008
-
负责人:PRAVEEN GAJENDRAREDDY
-
依托单位:
海外基金